Directory
>
David Scott Arrington
David Scott Arrington
Former SVP, Investor Relations & Corporate Affairs | Revolution Medicines
San Francisco, California, United States
David Scott Arrington
Summary
David Scott Arrington is a seasoned entrepreneurial leader and biotech executive with over two decades of experience in investor relations and corporate communications within the biotechnology, pharmaceutical, and life sciences sectors. He has a proven ability to drive growth and foster collaboration while simplifying complex scientific concepts for diverse audiences. Notably, David has successfully increased analyst coverage and strengthened investor bases through strategic market intelligence initiatives. His leadership has been instrumental during significant corporate transitions, including CEO changes and restructures. David's extensive background spans small to large-cap healthcare organizations, including Fortune 500 companies, showcasing his versatility in various corporate environments. He is passionate about research and innovation, with a strong commitment to engaging stakeholders in multicultural settings. David is always eager to connect with industry peers and explore new opportunities for growth and collaboration.
David Scott Arrington
Work Experience
Former SVP, Investor Relations & Corporate Affairs at
Revolution Medicines
March 2022 - Present
VP, Investor Relations & Corporate Communications at
FreeLine LTD.
January 2020 - January 2022
VP, Investor Relations, Corporate Communications & Government Affairs at
Coherus BioSciences
January 2018 - January 2020
VP, Investor Relations & Corporate Communications at
ACHAOGEN UK LTD
January 2017 - January 2018
Chief Marketing (Brand) Officer at
Leland Stanford Junior University
January 2015 - January 2017
Associate Vice Chancellor, (Vice President) University Relations at
University of California, San Francisco
January 2011 - January 2015
Senior Director, Corporate Relations at
Elan Pharmaceuticals
January 2009 - January 2011
Associate Director, Corporate Relations at
Genentech Foundation
January 2005 - January 2009
Associate Manager, Global Communications at
Bristol Myers Squibb
January 1999 - January 2005
David Scott Arrington
Education
University of Wales Trinity Saint David
Washington State University, Bachelor Of Arts, Cum Laude
Frequently Asked Questions about David Scott Arrington
What is David Scott Arrington email address?
David Scott Arrington's primary email address is *****@revmed.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Scott Arrington work for?
David Scott Arrington is a Former SVP, Investor Relations & Corporate Affairs at Revolution Medicines, a company specializing in Commercial physical research.
Where David Scott Arrington graduated from?
David Scott Arrington holds a degree in Philosophy from University of Wales Trinity Saint David.
How can I directly contact David Scott Arrington?
To contact David Scott Arrington directly, you can use the email address *****@revmed.com. Complete contact information is available upon registration with Muraena.
Who is David Scott Arrington?
David Scott Arrington is a seasoned entrepreneurial leader and biotech executive with over two decades of experience in investor relations and corporate communications within the biotechnology, pharmaceutical, and life sciences sectors. He has a proven ability to drive growth and foster collaboration while simplifying complex scientific concepts for diverse audiences. Notably, David has successfully increased analyst coverage and strengthened investor bases through strategic market intelligence initiatives. His leadership has been instrumental during significant corporate transitions, including CEO changes and restructures. David's extensive background spans small to large-cap healthcare organizations, including Fortune 500 companies, showcasing his versatility in various corporate environments. He is passionate about research and innovation, with a strong commitment to engaging stakeholders in multicultural settings. David is always eager to connect with industry peers and explore new opportunities for growth and collaboration.
David`s contact details
*****@revmed.com
**********@coherus.com
Colleagues
VP, Corporate Development
Vice President, FP&A and Strategy
Vice President - Clinical Data Science, Analytics, & Systems
Sr. Vice President, Pharmaceutical Development and Manufacturing
SVP, Medicinal Chemistry
Vice President Commercial Development
Co-Founder, Chairman & CEO
Vice President, Head of Quantitative Sciences
VP, Head of Information Security
CFO at REVOLUTION Medicines